Jennifer Singleterry, MA, speaks about the wide-ranging implications for cancer care and the associated costs in relation to health care and insurance reform.
The future of clinical pathways largely depends on alternative payment models such as the Oncology Care Model sponsored by CMS, according to Edward Stepanski, PhD.
Journal of Clinical Pathways spoke with Tudor Borza, MD, clinical lecturer in urology at University of Michigan Medical School, Ann Arbor, MI.
Journal of Clinical Pathways spoke with David A Hughes, BSN, about how the Seattle Cancer Care Alliance integrates the patient viewpoint and a collective understanding of value into clinical pathway practice.
Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning value-based care, health care reform, and clinical pathways.
The role of targeted therapies and clinical pathways in shaping future treatment practices for marginal zone lymphoma.
Journal of Clinical Pathways spoke with Dana A Telem, MD, MPH, to better understand the role clinical pathways can play in standardizing bariatric surgery practices.
Journal of Clinical Pathways spoke with Reshma Jagsi, MD, DPhil, professor and deputy chair of the department of radiation oncology.
Journal of Clinical Pathways spoke with Winston Wong, PharmD, editor-in-chief about the role of clinical pathways and value-based care in health care reform.
Benjamin Djulbegovic, MD, PhD, speaks about the need for effective entry points to discuss palliative care for patients with cancer.